Related Experiment Video
Updated: Jul 12, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Phosphoarginine modulates oligomerization and repressor activity of mycobacterial ClpC2
Henry R Anderson1, Pratistha Kandel2, Emmanuel C Ogbonna2,3
1Department of Chemistry & Biochemistry, University of Delaware, Newark, DE 19716.
Abstract:
Phosphoarginine (pArg) modifications direct proteins for proteolytic destruction by ClpC1P1P2, an essential mycobacterial protease that has emerged as a promising antibacterial drug target against Mycobacterium tuberculosis. The broader regulatory landscape surrounding pArg is poorly understood. Here, we establish a mechanistic connection between pArg binding and the activity of ClpC2, a non-proteolytic transcriptional repressor with homology to the ClpC1 N-terminal domain. Biophysical studies reveal that ClpC2 forms concentration-dependent higher-order oligomers that bind cooperatively to operator sequences in the clpC2 promoter. A high-resolution crystal structure of the Streptomyces thermoviolaceus ClpC2 C-terminal domain reveals a conserved dimerization interface mediated by a C-terminal helix, which is sterically disrupted by pArg binding. Consequently, we find that binding of pArg, as well as some ClpC1-targeting antibiotics, disrupts ClpC2 oligomerization, dissociates ClpC2 from its operator DNA, and relieves transcriptional repression in vitro. Moreover, comparative analysis of clpC2 promoters with single versus dual operator sites predicts differences in regulatory sensitivity across mycobacterial species. Together, these findings establish ClpC2 as a pArg-responsive sensor capable of mechanistically linking elevated pArg levels to downstream transcriptional regulation.
Insights
Phosphoarginine (pArg) modifies ClpC2, a transcriptional repressor, affecting its DNA binding and gene regulation. This discovery links pArg levels to bacterial gene expression, offering new insights into Mycobacterium tuberculosis.
Area of Science:
- Molecular Biology
- Biochemistry
- Microbiology
Background:
- Phosphoarginine (pArg) modifications target proteins for degradation by ClpC1P1P2, a key protease in Mycobacterium tuberculosis.
- The regulatory roles of pArg modifications are not well understood.
- ClpC2 is a non-proteolytic repressor homologous to ClpC1, suggesting a potential link to pArg regulation.
Purpose of the Study:
- To investigate the mechanistic connection between pArg binding and ClpC2 activity.
- To understand how pArg influences transcriptional regulation in mycobacteria.
- To explore ClpC2 as a potential drug target or regulator.
Main Methods:
- Biophysical studies to analyze ClpC2 oligomerization and DNA binding.
- High-resolution crystal structure determination of the ClpC2 C-terminal domain.
- In vitro assays to assess the effect of pArg and antibiotics on ClpC2 activity.
- Comparative analysis of clpC2 promoter sequences.
Main Results:
- ClpC2 forms higher-order oligomers that bind cooperatively to the clpC2 promoter.
- pArg binding sterically disrupts the ClpC2 dimerization interface.
- pArg and certain antibiotics dissociate ClpC2 from DNA, relieving transcriptional repression.
- Differences in clpC2 promoter operator sites predict varied regulatory sensitivity across species.
Conclusions:
- ClpC2 functions as a pArg-responsive sensor.
- pArg levels can be mechanistically linked to downstream transcriptional regulation.
- This study provides novel insights into the regulatory landscape of pArg modifications in mycobacteria.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Amplifying Signals via Enzymatic Cascade

